Sysmex six-month profit attributable to owners of parent falls 6% to JPY 17.93 billion

• Sysmex's six-month profit attributable to owners of the parent fell 6% to JPY 17.93 billion through September 30, 2026.
• Net sales climbed 17% year over year to JPY 272.82 billion, with overseas growth supported by hematology demand and yen depreciation.
• Impairment losses totaled JPY 5.77 billion, including goodwill and other assets associated with the Sysmex BioMajesty acquisition.
• For the year ending March 31, 2027, forecasts call for net sales of JPY 550 billion and attributable profit of JPY 40 billion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sysmex Corporation published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.